Clinical Trial Update: The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination of mesenchymal stem cells, HA-CaSO4, BMP-2, and an implant to promote healing of critical-sized bone defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Nonunion

Drugs mentioned

• BMP-2 (bone morphogenetic protein-2)
• HA-CaSO4 (hydroxyapatite-calcium sulfate)
• Implant
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Indonesia University | Conditions: Union | Phase 1 | Status: UNKNOWN